InvestorsHub Logo
Followers 403
Posts 25660
Boards Moderated 0
Alias Born 10/28/2017

Re: SPORT19 post# 4669

Monday, 12/11/2017 4:08:47 PM

Monday, December 11, 2017 4:08:47 PM

Post# of 7900
Hmm- I never said ISRG was going to buy TRXC, nor have I ever suggested it as a good idea. where you get that from?

when you are a publicly traded company your responsibility is to the shareholders and major changes are voted on by the board. company purchase decisions are run by bean counters looking to increase bottom line profit and ER numbers. no one on the board would approve spending even 10m on updating their robotic tech because of the monopoly. its not like a hospital is going to buy anyone else's lapro bot, newer or not.

Your view of the FDA clearance info is completely wrong.

FDA reports as follows: "FDA concluded that these study data, supported by real-world evidence, along with performance testing under simulated use and worst-case scenario conditions, demonstrated the substantial equivalence of the Senhance System to the da Vinci Si IS3000 device for gynecological and colorectal procedures."

Laymen terms "equally effective" = "substantial equivalence", syn.

e.g. : "substantial" and "equivalent" - google definition of those words. are you sure you know what "equivalent" means?

FDA demonstrated that the Senhance device is substantially equivalent to a legally marketed predicate device (DaVinci).

FDA granted clearance of the Senhance System to TransEnterix Surgical Inc.

If FDA test had only shown Senhance to be "similar" as you claim, it would have failed.

JMO, it's not cool to offer false facts in a stock message forum.

here is the FDA report: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm580452.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASXC News